NCT04398303View on ClinicalTrials.gov

ACT-20 in Patients With Severe COVID-19 Pneumonia

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
COVID-19 Pneumonia
Interventions
BIOLOGICAL

ACT-20-MSC

1 million cells / kg body weight in 100 ml in conditioned media

BIOLOGICAL

ACT-20-CM

100 ml of conditioned media only

BIOLOGICAL

Placebo

100 ml of MEM-α

Sponsors
All Listed Sponsors
lead

Aspire Health Science

OTHER